Let's collaborate and create quality liposome encapsulated drugs together. Contact Us!
SyVento BioTech is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. We specialize in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products.
Genetic platform
SyVento BioTech’s R&D Team offers technical and scientific support throughout the entire process, including advice on troubleshooting and optimization of RNA synthesis conditions. Our RNA synthesis proficiency guarantees successful results in downstream applications.
By incorporating these important features, our genetic platform for RNA synthesis
provides:
Delivery platform
Our Team’s qualifications and experience provide a wealth of expertise in the development of lipid-based delivery systems.
SyVento BioTech’s LNP delivery systems:
Manufacturing platform
Our capabilities offer the possibility of scaling the production of formulations based on lipid nanocarriers by transferring solutions developed in the laboratory on a semi-technical and technical scale.
Thanks to the extensive equipment base, we are able to perform:
Drug development expertise
September 3, 2026
Meet SyVento BioTech at Nordic Life Science Days 2026 in StockholmSyVento BioTech will be joining Nordic Life Science Days 2026, taking place on 8-9 September at Kistamässan in Stockholm. Meet our team at the Polish National Pavilion, stand F:12, and explore how an integrated CDMO partner can help move your nucleic acid-based therapy from development toward GMP manufacturing and clinical supply. Nordic Life Science Days […]
August 31, 2026
SyVento BioTech to Join DefenceTech Cluster at MSPO 2026 in Kielce (PL)SyVento BioTech will join DefenceTech Cluster and its partners during MSPO 2026 in Kielce, one of the key defence and security industry events in Central and Eastern Europe. On 10 September 2026, representatives of industry, technology, public administration, research organisations and the defence ecosystem will meet at Targi Kielce to discuss how innovation, available funding […]
August 10, 2026
SyVento Supports BioResearch Pharma Therapy Program Through Phase I ManufacturingWe are delighted to inform that our ongoing manufacturing partnership with BioResearch Pharma (BRP), supporting the development and production of BRP-007 (psoriasis), moved to the next phase of the technical batch production. BRP is a company developing novel topical dermatological therapies based on repurposing of known and market-authorized active substances. The collaboration between companies covers […]
August 7, 2026
SyVento Partners with nCode to Deliver a Smarter End-to-End Workflow for mRNA Therapeutic DevelopmentSyVento BioTech is pleased to announce a strategic partnership with nCode, a company specializing in AI-driven mRNA sequence optimization and computational design. Together, we offer biotech and pharmaceutical innovators a more integrated development pathway, from optimized mRNA/LNP design to clinical-ready drug product manufacturing. Complementary Expertise Across the Development Process The partnership combines two highly specialized […]
July 30, 2026
SyVento Biotech Partners with Biotechna for siRNA/LNP Onco Therapeutics ProgramBiotechna and SyVento Biotech entered into a strategic partnership for project „Design and development of nanoparticle RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”. The project is funded by grant from Medical Research Agency (Agencja Badań Medycznych – ABM; ABM/2022/6). […]
July 23, 2026
Pharmaceutical Sovereignty Is National SecurityInterview with Tomasz Piec, Chairman of the Supervisory Board of SyVento BioTech The COVID-19 pandemic, geopolitical instability and disruptions to global supply chains have fundamentally changed the way we think about security. Alongside defence, energy and cybersecurity, biotechnology is increasingly recognised as a strategic capability. Why could the ability to develop and manufacture medicines become […]
June 26, 2026
Syvento at EUROBIOTECH 2026: Driving the Conversation on the Future of Polish BiotechnologyWe are pleased to announce that Syvento will participate in the 10th Central European Congress of Life Sciences – EUROBIOTECH 2026, one of the leading biotechnology and life sciences events in Central Europe. Taking place on 2–3 July 2026 in Kraków, the anniversary edition of the congress will bring together scientists, biotechnology companies, industry leaders, […]
June 19, 2026
SyVento BioTech at BIO 2026: Building Partnerships That Accelerate InnovationBIO International Convention 2026 brings together the global biotechnology community to explore new scientific breakthroughs, strategic partnerships, and opportunities that shape the future of healthcare. This year, SyVento BioTech will join industry leaders in San Diego to connect with biotech innovators, pharmaceutical companies, investors, and technology partners seeking to accelerate the development and commercialization of […]
June 19, 2026
SyVento BioTech Joins DefenceTech Cluster Initiative at the Horizon of Security CongressKielce, Poland – June 2026 SyVento BioTech has joined a group of leading organizations from industry, academia, technology, and critical infrastructure sectors in launching the DefenceTech Cluster / Horizon of Security initiative (Horyzont Bezpieczeństwa). The project aims to strengthen Poland’s technological resilience, strategic autonomy, and innovation capabilities through cross-sector collaboration. The initiative was presented during […]
Let's collaborate and create quality liposome encapsulated drugs together.